Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors Publisher



Aghamir SMK1 ; Heshmat R2 ; Ebrahimi M3 ; Khatami F1
Authors

Source: Epigenetics Insights Published:2020


Abstract

Blood test is a kind of liquid biopsy that checks cancer cells or cancer nucleic acids circulating freely from cells in the blood. A liquid biopsy may be used to distinguish cancer at early stages and it could be a game-changer for both cancer diagnosis and prognosis strategies. Liquid biopsy tests consider several tumor components, such as DNA, RNA, proteins, and the tiny vesicles originating from tumor cells. Actually, liquid biopsy signifies the genetic alterations of tumors through nucleic acids or cells in various body fluids, including blood, urine, cerebrospinal fluid, or saliva in a noninvasive manner. In this review, we present an overall description of liquid biopsy in which circulating tumor cells, cell-free nucleic acids, exosomes, and extrachromosomal circular DNA are included. © The Author(s) 2020.
Related Docs
View other Related Docs
1. Liquid Biopsy in Thyroid Cancer: New Insight, International Journal of Hematology-Oncology and Stem Cell Research (2018)
2. Potential Theranostics of Circulating Tumor Cells and Tumor-Derived Exosomes Application in Colorectal Cancer, Cancer Cell International (2020)
3. Circulating Tumor Dna (Ctdna) in the Era of Personalized Cancer Therapy, Journal of Diabetes and Metabolic Disorders (2018)
Experts (# of related papers)
View all Related Experts
Seyed Mohammad Tavangar (6)
Bagher Larijani (4)
Other Related Docs
4. Overview of Liquid Biopsy, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
5. The Presence of Tumor Extrachomosomal Circular Dna (Ecdna) As a Component of Liquid Biopsy in Blood, Medical Hypotheses (2018)
6. Liquid Biopsy As a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations, International Journal of Molecular and Cellular Medicine (2019)
7. Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer, Molecular Therapy Nucleic Acids (2018)
8. Prediction of the Treatment Response in Ovarian Cancer: A Ctdna Approach, Journal of Ovarian Research (2020)
9. Liquid Biopsy in Kidney Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
10. The Potential of Circulating Tumor Cells in Personalized Management of Breast Cancer: A Systematic Review, Acta Medica Iranica (2017)
11. Hypermethylated Rassf1 and Slc5a8 Promoters Alongside Brafv600e Mutation As Biomarkers for Papillary Thyroid Carcinoma, Journal of Cellular Physiology (2020)
12. Prognostic and Therapeutic Significance of Circulating Tumor Cells in Patients With Lung Cancer, Cellular Oncology (2020)
13. Emerging Role of Micrornas As Liquid Biopsy Biomarkers in Lung Cancer: A Review, Acta Medica Iranica (2021)
14. Liquid Biopsy in Bladder Tumors, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
15. Common Molecular Markers Between Circulating Tumor Cells and Blood Exosomes in Colorectal Cancer: A Systematic and Analytical Review, Cancer Management and Research (2019)
16. Recent Advances in the Roles of Exosomal Micrornas (Exomirs) In Hematologic Neoplasms: Pathogenesis, Diagnosis, and Treatment, Cell Communication and Signaling (2023)
17. Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications, Current Medicinal Chemistry (2021)
18. Current Biological Implications and Clinical Relevance of Metastatic Circulating Tumor Cells, Clinical and Experimental Medicine (2025)
19. Paper-Based Biosensors As Point-Of-Care Diagnostic Devices for the Detection of Cancers: A Review of Innovative Techniques and Clinical Applications, Frontiers in Oncology (2023)
20. Human Uterine Fluid Lavage-Derived Extracellular Vesicle Isolation: A Comparative Study for Minimally Invasive Endometrial Receptivity Assessment, Reproductive BioMedicine Online (2022)